Results 131 to 140 of about 43,089 (386)

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction [PDF]

, 2018
Background: Information on the pathophysiological differences between heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) is needed Objectives: The purpose of this study was to establish ...
Anker, Stefan D., Cleland, John G. F., Dickstein, Kenneth, Filippatos, Gerasimos S., Hillege, Hans L., Lang, Chim, Metra, Marco, Ng, Leong Loke, Ouwerkerk, Wouter, Ponikowski, Piotr, Samani, Nilesh J., Tromp, Jasper, van der Harst, Pim, van der Meer, Peter, van Veldhuisen, Dirk Jan, Voors, Adriaan A., Westenbrink, Daan, Zannad, Faiez, Zwinderman, Aelko H.   +18 more
core   +3 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Heart failure with preserved ejection fraction based on aging and comorbidities

Journal of Translational Medicine, 2021
Heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause of hospitalizations and mortality when diagnosed at the age of ≥ 65 years.
Ying Lin, Shihui Fu, Yao Yao, Yulong Li, Yali Zhao, Leiming Luo   +5 more
doaj   +1 more source

HFpEF

JACC: Heart Failure, 2018
![Figure][1] We have dedicated the August issue of JACC: Heart Failure to the condition of HFpEF—heart failure with preserved ejection fraction. I recall as a house officer in the mid-1980s taking care of patients on the cardiology service with HF and concomitant pulmonary edema.
openaire   +3 more sources

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundUnderlying inflammation has been increasingly recognized in heart failure with a preserved ejection fraction (HFpEF). In this study we tested the hypothesis that pro‐inflammatory biomarkers are elevated in patients with acutely decompensated ...
Abraham Abernethy, Sadi Raza, Jie‐Lena Sun, Kevin J. Anstrom, Russell Tracy, Johannes Steiner, Peter VanBuren, Martin M. LeWinter   +7 more
doaj   +1 more source

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction? [PDF]

, 2018
K
Alogna, A., Hamdani, Nazha, Kovács, Árpád, Post, H.   +3 more
core   +1 more source

ACE inhibitors and ARBs in HFpEF [PDF]

Nature Reviews Cardiology, 2012
Renin-angiotensin-system (RAS) inhibitors have proven efficacy in patients who have heart failure with reduced ejection fraction (HFrEF). A registry study has now assessed the use of RAS inhibitors in patients defined as having heart failure with preserved ejection fraction (HFpEF) in a 'real-world' setting.
openaire   +3 more sources

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

A Randomised Controlled Trial of a Facilitated Home-Based Rehabilitation Intervention in Patients with Heart Failure with Preserved Ejection Fraction and their Caregivers:The REACH-HFpEF Pilot Study [PDF]

, 2018
Introduction Home-based cardiac rehabilitation may overcome suboptimal rates of participation. The overarching aim of this study was to assess the feasibility and acceptability of the novel Rehabilitation EnAblement in CHronic Hear Failure (REACH-HF ...
Abraham, Charles, Britten, Nicholas, Dalal Hayes, M., Davis, Russell C., Doherty, Patrick, Eyre, Victoria, Greaves, Colin J., Green, Colin, Hayward, Christopher, Hillsdon, Melvyn, Jolly, Kate, Lang, Chim C., Miles, Jackie, Paul, Kevin, Sadler, Susannah, Singh, Sally, Smith, Karen, Taylor, Rod S ., Van Lingen, Robin, Warren, Fiona C., Wingham, Jenny   +20 more
core   +7 more sources